Literature DB >> 34687156

If the mountain won't come to Mohammed, then Mohammed must go to the mountain: Decentralisation of hepatitis C care for people who use drugs.

Daan W Von den Hoff1, Floor A C Berden1, Arnt F A Schellekens2,3,4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34687156      PMCID： PMC8672080          DOI： 10.1002/ueg2.12167

Source DB:  PubMed          Journal:  United European Gastroenterol J        ISSN： 2050-6406            Impact factor:   4.623


× No keyword cloud information.
  7 in total

1.  The majority of hepatitis C patients treated with direct acting antivirals are at risk for relevant drug-drug interactions.

Authors:  Elise J Smolders; Floor Ac Berden; Clara Tmm de Kanter; Wietske Kievit; Joost Ph Drenth; David M Burger
Journal:  United European Gastroenterol J       Date:  2016-11-04       Impact factor: 4.623

2.  Hepatitis C Guidance 2019 Update: American Association for the Study of Liver Diseases-Infectious Diseases Society of America Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection.

Authors:  Marc G Ghany; Timothy R Morgan
Journal:  Hepatology       Date:  2020-02       Impact factor: 17.425

Review 3.  Hepatitis C virus therapy in advanced liver disease: Outcomes and challenges.

Authors:  Sirina Ekpanyapong; K Rajender Reddy
Journal:  United European Gastroenterol J       Date:  2019-03-21       Impact factor: 4.623

4.  EASL recommendations on treatment of hepatitis C: Final update of the series☆.

Authors: 
Journal:  J Hepatol       Date:  2020-09-15       Impact factor: 25.083

5.  Decentralisation, integration, and task-shifting in hepatitis C virus infection testing and treatment: a global systematic review and meta-analysis.

Authors:  Ena Oru; Adam Trickey; Rohan Shirali; Steve Kanters; Philippa Easterbrook
Journal:  Lancet Glob Health       Date:  2021-02-24       Impact factor: 26.763

Review 6.  Loss to follow-up in the hepatitis C care cascade: A substantial problem but opportunity for micro-elimination.

Authors:  Marleen van Dijk; Joost P H Drenth
Journal:  J Viral Hepat       Date:  2020-09-22       Impact factor: 3.728

7.  Increased Hepatitis C virus screening, diagnosis and linkage to care rates among people who use drugs through a patient-centered program from Italy.

Authors:  Alessandra Mangia; Maria Franca Rina; Antonio Canosa; Valeria Piazzolla; Maria Maddalena Squillante; Ernesto Agostinacchio; Giovanna Cocomazzi; Egidio Visaggi; Nazario Augello; Camilla Iannuzziello; Mattia Falcone; Angelo De Giorgi; Fausto Campanozzi
Journal:  United European Gastroenterol J       Date:  2021-10-26       Impact factor: 4.623
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.